Table 2.

Type of drugs received by the noADMCI patients of the present study.

Drugs	noADMCI-noEEA	noADMCI-EEA
Selective serotonin reuptake inhibitors (SSRIs)	Citalopram, Escitalopram Sertraline	Citalopram, Escitalopram
Selective serotonin and noradrenaline reuptake inhibitors (SNRIs)	Venflaxine	No drugs
Benzodiazepine (BZD)	Alprazolam, Midazolam Lorazepam	Bromapezam, Diazepam Lorazepam
Non-benzodiazepine GABA acting agent (No BZD)	Zolpidem	No drugs
Acetylcholinesterase inhibitor (AChEI)	Donepezil, Rivastigmine	Donepezil

The drugs were categorized into 5 pharmacodynamic classes: selective serotonin reuptake inhibitors (SSRIs), selective serotonin and noradrenaline reuptake inhibitors (SNRIs), benzodiazepines (BZDs), non-benzodiazepines GABA acting agent (No BZDs), and acetylcholinesterase inhibitors (AChEIs).